Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-19-004952
Filing Date
2019-04-29
Accepted
2019-04-29 17:07:20
Documents
4
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rgls20181231-10ka.htm 10-K/A 442438
2 EXHIBIT 31.3 a201810kaex-313xcertofprin.htm EX-31.3 6934
3 EXHIBIT 31.4 a201810kaex-314xcertofprin.htm EX-31.4 6949
4 regimage.jpg GRAPHIC 14038
  Complete submission text file 0001628280-19-004952.txt   476810
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35670 | Film No.: 19776965
SIC: 2834 Pharmaceutical Preparations